Polypyrrolinone Project – Smith/Hirschmann Collaboration (1987-2011)
In collaboration with Professor Ralph Hirschmann we have developed the nitrogen-displaced and carbonyl-displaced pyrrolinone scaffolds were designed to mimic both the hydrogen-bonding pattern and side-chain orientation of the b-sheet/b-strand conformation of peptides.The success of this design led to the development of potent pyrrolinone-based inhibitors of several proteolytic enzymes including HIV-1 protease, Renin, and matrix metalloproteases. More recently, we have extended the utility of the pyrrolinone scaffold by demonstrating that simple structural modifications lead to turned conformations mimicking the peptidal b-turn. Current pyrrolinone research is focused on improving the potency of our HIV-1 protease inhibitors and further development of the pyrrolinones as peptidomimetic scaffolds capable of adopting b-strand, b-turn, and helical conformations.
Referenced Publications:
J. L. Wood, D. R. Jones, R. Hirschmann and A. B. Smith, III. A Versatile, Efficient Synthesis of (–) (2S, 3R, 4S)-2-Amino-1-cyclohexyl-3,4-dihydroxy-6-methylheptane, The Abbott Pseudodipeptidyl Insert. Tetrahedron Lett. 1990, 31, 6329-6330.
A. B. Smith, III, T. P. Keenan, R. C. Holcomb, P. A. Sprengeler, M. C. Guzman, J. L. Wood, P. J. Carroll, and R. Hirschmann. Design, Synthesis, and Crystal Structure of a Pyrrolinone-Based Peptidomimetic Possessing the Conformation of a β-Strand: Po
A. B. Smith, III, R. C. Holcomb, M. C. Guzman, T. P. Keenan, P. A. Sprengeler, and R. Hirschmann. An Effective Synthesis of Scalemic 3,5,5-Trisubstituted Pyrrolin-4-ones. Tetrahedron Lett. 1993, 34, 63-66.
A. B. Smith, III, R. Hirschmann, A. Pasternak, R. Akaishi, M. C. Guzman, D. R. Jones, T. P. Keenan, P. A. Sprengeler, P. L. Darke, E. A. Emini, M. K. Holloway, and W. A. Schleif. Design and Synthesis of Peptidomimetic Inhibitors of HIV-1 Protease an
A. B. Smith, III, M. C. Guzman, P. A. Sprengeler, T. P. Keenan, R. C. Holcomb, J. L. Wood, P. J. Carroll, and R. Hirschmann. De Novo Design, Synthesis, and X-ray Crystal Structures of Pyrrolinone-Based β-Strand Peptidomimetics. J. Am. Chem. Soc. 19
Smith, III, Amos B.; Akaishi, Ryouichi; Jones, David R.; Keenan, Terence P.; Guzman, Mark C.; Holcomb, Ryan C.; Sprengeler, Paul A.; Wood, John L.; Hirschmann, Ralph; Holloway, M. Katharine. Design and synthesis of nonpeptide peptidomimetic inhibitors of
Smith, Amos B,. III; Hirschmann, Ralph; Pasternak, Alexander; Guzman, Mark C.; Yokoyama, Akihisa; Sprengeler, Paul A.; Darke, Paul L.; Emini, Emilio A.; Schleif, William A. Pyrrolinone-Based HIV Protease Inhibitors. Design, Synthesis, and Antiviral Activi
Smith, Amos B., III; Hirschmann, Ralph; Pasternak, Alexander; Yao, Wenquing; Sprengeler, Paul A.; Holloway, M. Katharine; Kuo, Lawrence C.; Chen, Zhongguo; Darke, Paul L.; Schleif, William A. An Orally Bioavailable Pyrrolinone Inhibitor of HIV-1 Protease:
Sudoh, Masao; Pauletti, Giovanni M.; Yao, Wenqing; Moser, William; Yokoyama, Akihisa; Pasternak, Alexander; Sprengeler, Paul A.; Smith, Amos B., III; Hirschmann, Ralph; Borchardt, Ronald T. Transport characteristics of peptidomimetics. Effect of the pyrro
Smith, Amos B. ,III; Benowitz, Andrew B.; Guzman, Mark C.; Sprengeler, Paul A.; Hirschmann, Ralph; Schweiger, Edwin J.; Bolin, David R.; Nagy, Zoltan; Campbell, Robert M.; Cox, Donald C.; Olson, Gary L. Design, synthesis, and evaluation of a pyrrolinone-p
Smith, Amos B., III; Favor, David A.; Sprengeler, Paul A.; Guzman, Mark C.; Carroll, Patrick J.; Furst, George T.; Hirschmann, Ralph. Molecular modeling, synthesis, and structures of N-methylated 3,5-linked pyrrolin-4-ones toward the creation of a privile
Smith, Amos B., III; Benowitz, Andrew B.; Sprengeler, Paul A.; Barbosa, Joseph; Guzman, Mark C.; Hirschmann, Ralph; Schweiger, Edwin J.; Bolin, David R.; Nagy, Zoltan; Campbell, Robert M.; Cox, Donald C.; Olson, Gary L. Design and Synthesis of a Competent
A. B. Smith, III, T. Nittoli, P. A. Sprengeler, J. J.-W. Duan, R.-Q. Liu, and R. F. Hirschmann. Design, Synthesis, and Evaluation of a Pyrrolinone-Based Matrix Metalloprotease Inhibitor. Org. Lett, 2000, 2, 3809-3812.
A. B. Smith, III, L.-D. Cantin, A. Pasternak, L. Guise-Zawacki, W. Yao, A. Charnleyl J. Barbosa, P. A. Sprengeler, R. Hirschmann, S. Munshi, D. B. Olsen, W. A. Schleif and L. C. Kuo. Design, Synthesis and Biological Evaluation of Monopyrrolinone-Bas
A. B. Smith, III, A. K. Charnley, E. F. Mesaros, O. Kikuchi, W. Wang, A. Benowitz, and R. Hirschmann. Design, Synthesis, and Biological Evaluation of Novel Pyrrolinone-Based Somatostatin Mimetics. Org. Lett. 2005, 7, 399-402.
A. B. Smith, III, A. K. Charnley, H. Harada, J. J. Beiger, L.-D. Cantin, C. S. Kenesky, R. Hirschmann, S. Munshi, D. B. Olsen, M. W. Stahlhut, W. A. Schleif, and L. C. Kuo. Design, Synthesis and Biological Evaluation of Monopyrrolinone-Based HIV-1 P
A. B. Smith, III, H. Xiong, A. K. Charnley, M. Brenner, E. F. Mesaros, C. S. Kenesky, L. di Costanzo, D. Christianson and R. Hirschmann. Design, Synthesis and Structural Analysis of D, L-Mixed Polypyrrolinones 2: Macrocyclic Hexapyrrolinones. Org.